Piper Therapeutics

About:

Drug discovery and development for moderating macrophages, with initial focus on immuno-oncology

Twitter/X: PiperThera

Description:

Piper Therapeutics is a pre-clinical drug discovery company that develops therapies for its clients. The company develops therapies for inflammatory signaling and immune system response. Furthermore, it develops macrophages that offers services in immuno-oncology. Piper Therapeutics was founded in 2015 by Russ Wilcox and is based in Cambridge.

Total Funding Amount:

$1.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2015-09-01

Contact Email:

info(AT)pipertx.com

Founders:

Russ Wilcox

Number of Employees:

1-10

Last Funding Date:

2016-05-20

IPO Status:

Private

Industries: